NCT06547645

Brief Summary

Skilled Nursing Facility at Home is a multicenter randomized control trial that aims to evaluate a home-based model of providing post-acute care (PAC). We will enroll 650 hospitalized patients who require rehabilitation and/or skilled-nursing support upon discharge and randomly assign them to an intervention (home-based PAC) or control arm (facility-based PAC). Our design includes two different health systems in Massachusetts: Baystate Health and UMass Memorial Health. We will perform 1:1 randomization between the intervention and control arm using a permuted block design, with stratification by clinical site and payor group. The primary outcome of the trial will be the difference in hospital readmission and mortality rates from the time of enrollment to 30 days after enrollment. Secondary clinical, functional, and cost outcomes include length of stay in PAC, difference in health-related quality of life (HRQoL), and healthcare cost and utilization.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
650

participants targeted

Target at P75+ for not_applicable

Timeline
12mo left

Started Aug 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Aug 2024May 2027

First Submitted

Initial submission to the registry

August 7, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 9, 2024

Completed
17 days until next milestone

Study Start

First participant enrolled

August 26, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

2.3 years

First QC Date

August 7, 2024

Last Update Submit

March 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • 30-Day Readmission and Mortality

    Hospital readmission rates and mortality rates between the intervention and control groups in the first 30 days after enrollment

    From time of enrollment to 30 days after enrollment

Secondary Outcomes (6)

  • 90- and 180- day Readmission and Mortality

    From time of enrollment, up to 6 months post-enrollment

  • Days Alive

    From time of enrollment, up to 6 months post-enrollment

  • Activities of Daily Living

    From time of enrollment, up to 6 months post-enrollment

  • Healthcare Costs

    From time of enrollment, up to 6 months post-enrollment

  • Mortality rate

    From time of enrollment to 6 months post-enrollment

  • +1 more secondary outcomes

Study Arms (2)

Facility-based

NO INTERVENTION

Facility based post acute care at a skilled nursing facility, as is the standard care model.

Home-based

ACTIVE COMPARATOR

Home-based Post-Acute Care

Other: Sub-Acute Rehab at Home

Interventions

Patients randomized to the intervention group will receive skilled nursing and rehabilitative care at home upon discharge from the hospital, or when eligible for skilled-nursing facility care when requiring a step up in services at home. Home care will be delivered and overseen by a multidisciplinary clinical team, which will develop individualized care plans based on diagnosis, specific rehabilitation objectives, and broader goals of care.

Also known as: SNF at Home
Home-based

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older
  • Admitted to an inpatient unit OR receiving home health and requiring an escalation to skilled-nursing facility care
  • Require post-acute care in a skilled nursing facility based on the clinical inpatient team's assessment (or, if the participant is coming from home, based on the home health team's assessment)
  • Pass the home readiness assessment
  • Reside within Greater Worcester or Greater Springfield

You may not qualify if:

  • Inability to return to a home residence where care can be provided
  • Inability for patient or their proxy to provide informed consent for the study
  • Requires long-term care
  • Requires palliative or hospice care
  • On active chemotherapy
  • Post-transplant surgery
  • Requires hemodialysis
  • Requires radiation therapy
  • Requires two-person assist or mechanical lift
  • Expresses unwillingness to be randomized to SNF OR SNF at Home care
  • Considered clinically inappropriate by SNF at Home clinical team

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Baystate Medical Center

Springfield, Massachusetts, 01199, United States

RECRUITING

UMass Memorial Medical Center

Worcester, Massachusetts, 02446, United States

RECRUITING

Study Officials

  • Principal Investigator

    University of Massachusetts, Worcester

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 7, 2024

First Posted

August 9, 2024

Study Start

August 26, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

May 1, 2027

Last Updated

March 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations